- Investing | July 25, 2012
Inconclusive Results for This Genome Sequencer
Illumina seems to be improving, but it's not out of the woods yet.
- Investing | July 24, 2012
Why Bruker Shares Plunged
Is this meaningful or just another movement?
- High-Growth Investing | July 20, 2012
CAPScall of the Week: Complete Genomics
A weekly adventure in giving unknown companies some attention.
- Investing | July 11, 2012
Has Affymetrix Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
- Investing | July 09, 2012
Why Sequenom's Sinking in 2012
Volatility hasn't produced lasting gains this year.
- Investing | June 26, 2012
Genomic Health: Bright Spot in a Tough Market
- Investing | June 16, 2012
Analysts Debate: Is Life Technologies a Top Stock?
Examining different perspectives can help you become a better investor.
- Investing | May 29, 2012
3 Stocks for Biotech's Future
- High-Growth Investing | April 25, 2012
Buy, Sell, or Hold: Sequenom
$1,000 genetic sequencing bodes well for this stock.
- High-Growth Investing | April 20, 2012
This Takeover Is Off the Table. Maybe.
Has Roche walked away from Illumina, or is it bluffing?